CIBC Asset Management Inc Increases Stock Position in DexCom, …

18 hours ago · CIBC Asset Management Inc raised its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 6.6% in the 3rd quarter, according to its most recent 13F …

CouponFollow Extension

6%
OFF

CIBC Asset Management Inc Increases Stock Position In DexCom, …

1 week from now

18 hours ago · CIBC Asset Management Inc raised its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 6.6% in the 3rd quarter, according to its most recent 13F …

marketbeat.com

15%
OFF

DexCom, Inc. - Dexcom Reports Second Quarter 2024 Financial …

1 week from now

Jul 25, 2024 · DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights: Revenue grew 15% …

dexcom.com

3%
OFF

Glucose Monitor Maker DexCom's Stock Soars After Big Earnings …

1 week from now

Oct 26, 2023 · Shares of DexCom Inc. (DXCM) shot up 15.3% to pace the S&P 500's after-hours gainers on Thursday, after of maker of glucose monitoring systems reported third-quarter profit …

morningstar.com

60%
OFF

Up 60%, Why I Believe DexCom Is One Of The Best Healthcare …

1 week from now

Dec 11, 2023 · DexCom's strong position in the healthcare sector is expected to continue in 2024 due to M&A activity and growth of GLP-1 drugs. Learn more on DXCM stock here.

seekingalpha.com

7%
OFF

CIBC Asset Management Inc Increases Stock Holdings In

1 week from now

18 hours ago · CIBC Asset Management Inc grew its stake in Freeport-McMoRan Inc. (NYSE:FCX - Free Report) by 7.7% in the 3rd quarter, according to its most recent filing with …

marketbeat.com

4%
OFF

CIBC Asset Management Inc Increases Stock Position In

1 week from now

2 days ago · CIBC Asset Management Inc increased its position in Medtronic plc (NYSE:MDT - Free Report) by 2.4% in the 3rd quarter, according to its most recent disclosure with the …

marketbeat.com

$451000
OFF

Los Angeles Capital Management LLC Has $451,000 Stock Position …

1 week from now

18 hours ago · DexCom Trading Up 1.6 %. NASDAQ DXCM opened at $75.88 on Friday. DexCom, Inc. has a 52 week low of $62.34 and a 52 week high of $142.00. The company has …

etfdailynews.com

15%
OFF

Dexcom Reports Second Quarter 2024 Financial Results, Updates …

1 week from now

Jul 25, 2024 · DexCom, Inc. today reported its financial results as of and for the quarter ended June 30, 2024. Revenue grew 15% year-over-year to $1.004 billion on a reported basis and …

nasdaq.com

6%
OFF

CIBC Asset Management Inc Increases Stock Position In

1 week from now

2 days ago · CIBC Asset Management Inc lifted its position in shares of Wheaton Precious Metals Corp. (NYSE:WPM - Free Report) by 10.6% during the third quarter, according to its most …

marketbeat.com

6%
OFF

CIBC Asset Management Inc Grows Stock Holdings In ... - MarketBeat

1 week from now

18 hours ago · CIBC Asset Management Inc raised its position in TransDigm Group Incorporated (NYSE:TDG - Free Report) by 8.6% during the third quarter, according to its most recent …

marketbeat.com

1%
OFF

CIBC Asset Management Inc Increases Stock Position In CME …

1 week from now

1 day ago · CIBC Asset Management Inc increased its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.1% in the 3rd quarter, according to its most recent …

marketbeat.com

4%
OFF

Asset Management One Co. Ltd. Raises Position In DexCom

1 week from now

Nov 6, 2024 · Asset Management One Co. Ltd. lifted its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 10.4% during the third quarter, according to its most …

marketbeat.com

FAQs about CIBC Asset Management Inc Increases Stock Position in DexCom, … Coupon?

How did Dexcom perform in the second quarter 2024?

SAN DIEGO-- (BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights: Revenue grew 15% year-over-year to $1.004 billion on a reported basis and 16% year-over-year on an organic 1 basis. ...

Is Dexcom (DXCM) a good stock to buy?

DexCom, Inc. DXCM reported better-than-expected third-quarter results on Thursday. DexCom Beats Earnings Expectations. Why the Stock Is Trading Lower. DexCom's U.S. revenue declines 2% in the third quarter from a year earlier. U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Friday. ...

Why did Dexcom shares fall?

Dexcom shares fell on Thursday after the company released third-quarter results that beat expectations but showed slow revenue growth. The company's revenue increased 2% from $975 million a year earli... ...

How can investors benefit from investing in Dexcom?

Here are some ways that investors could benefit from investing in DexCom, Inc.: DexCom, Inc. is a medical device company that focuses on continuous glucose monitoring (CGM) systems, a growing market due to the increasing prevalence of diabetes worldwide. ...

Did Dexcom beat Wall Street estimates for third-quarter revenue?

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients. SAN DIEGO-- (BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2024. ...

Will Dexcom continue to outperform the healthcare sector in 2024?

DexCom is expected to remain an outperformer in the healthcare sector in 2024, driven by M&A activity and the growth of GLP-1 weight loss drugs. The company's continuous glucose monitoring ("CGM") solutions are complementary to GLP-1 therapies and may even increase demand for DexCom's products. ...